首页> 外文期刊>Clinical and experimental metastasis >Bone targeted bipolar cooled radiofrequency ablation in a VX-2 rabbit femoral carcinoma model
【24h】

Bone targeted bipolar cooled radiofrequency ablation in a VX-2 rabbit femoral carcinoma model

机译:VX-2兔股骨癌模型中的骨靶向双极冷却射频消融

获取原文
获取原文并翻译 | 示例
           

摘要

To determine the effect of bipolar cooled radiofrequency ablation (BCRF) on bone and tumour in a lapine pathologic femoral model. Under institutional approval, twelve New Zealand white rabbits received a single femoral injection of VX2 carcinoma cells (day 0). The rabbit femora, (n = 24), were block-randomized into four experimental groups: tumour-bearing radiofrequency ablation (RFA) treated, healthy bone RFA treated, tumour-bearing shams and healthy bone shams (n = 6 per group). 15 min of thermally regulated (65 A degrees C) BCRF was applied at day 14. Pre- and post-treatment MR imaging was performed and repeated at day 28 prior to euthanasia. Histologic evaluation was used to determine treatment effect on tumour and bone tissue. A thirteenth injected rabbit served as a histologic control (no BCRF electrode placement). Large volumes (12.9 +/- A 5.5 cm(3)) of thermal ablation were achieved. An eight-fold reduction in tumour growth resulted in RFA treated animals compared to tumour-bearing sham controls (p < 0.001). Osteolysis was controlled in the tumour-treated group. Therapeutic effects were best imaged using MR contrast-enhanced SPoiled Gradient Recalled (SPGR) sequences. Osteoclasts and osteoblasts were observed to be sensitive to BCRF but osteocytes were more resilient. A small number of tumour cells within BCRF treated regions appeared viable post treatment. New bone formation was stimulated in the periphery of the targeted BCRF treatment zone. Structurally large VX2 tumour volumes within bone were successfully ablated with BCRF, stimulating new bone formation in the treatment periphery, although viable appearing osteocytes and tumour cells were observed in some treated regions.
机译:要确定双极冷却射频消融(BCRF)对骨骼病理性股骨模型中骨骼和肿瘤的影响。在机构批准下,十二只新西兰白兔接受了股静脉注射VX2癌细胞(第0天)。将兔股骨(n = 24)分为四个实验组:荷瘤射频消融(RFA)治疗,健康骨骼RFA治疗,荷瘤tum毛和健康骨sha毛(每组n = 6)。在第14天应用15分钟的热调节(65 A摄氏度)BCRF。在安乐死之前的28天进行治疗前和治疗后MR成像,然后重复进行。组织学评估用于确定对肿瘤和骨组织的治疗效果。注射的第十三只兔子用作组织学对照(不放置BCRF电极)。实现了大体积(12.9 +/- A 5.5 cm(3))的热消融。与荷瘤假手术对照组相比,RFA处理的动物的肿瘤生长减少了八倍(p <0.001)。肿瘤治疗组的骨溶解得到控制。使用MR对比增强的SPoiled Gradient Recall(SPGR)序列对治疗效果进行最佳成像。观察到破骨细胞和成骨细胞对BCRF敏感,但成骨细胞更具弹性。 BCRF治疗区域内的少量肿瘤细胞在治疗后似乎可行。在目标BCRF治疗区的周围刺激了新的骨形成。尽管在某些治疗区域观察到有活力的骨细胞和肿瘤细胞出现,但使用BCRF成功消融了骨内结构性大的VX2肿瘤体积,刺激了治疗周围的新骨形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号